Jade Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JBIO and other ETFs, options, and stocks.About JBIO
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.
CEOTom Frohlich
CEOTom Frohlich
Employees55
Employees55
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2018
Founded2018
Employees55
Employees55
JBIO Key Statistics
Market cap672.67M
Market cap672.67M
Price-Earnings ratio-2.56
Price-Earnings ratio-2.56
Dividend yield—
Dividend yield—
Average volume414.43K
Average volume414.43K
High today$14.06
High today$14.06
Low today$13.50
Low today$13.50
Open price$14.02
Open price$14.02
Volume37.81K
Volume37.81K
52 Week high$100.10
52 Week high$100.10
52 Week low$6.57
52 Week low$6.57
Stock Snapshot
With a market cap of 672.67M, Jade Biosciences(JBIO) trades at $13.64. The stock has a price-to-earnings ratio of -2.56.
As of 2026-03-18, Jade Biosciences(JBIO) stock has fluctuated between $13.50 and $14.06. The current price stands at $13.64, placing the stock +1.0% above today's low and -3.0% off the high.
Jade Biosciences(JBIO) shares are trading with a volume of 37.81K, against a daily average of 414.43K.
In the last year, Jade Biosciences(JBIO) shares hit a 52-week high of $100.10 and a 52-week low of $6.57.
In the last year, Jade Biosciences(JBIO) shares hit a 52-week high of $100.10 and a 52-week low of $6.57.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own JBIO. This list is generated using Robinhood data, and it’s not a recommendation.